Castle Biosciences (NASDAQ:CSTL – Free Report) had its price target increased by Canaccord Genuity Group from $37.00 to $50.00 in a research report report published on Monday morning, Marketbeat Ratings reports. Canaccord Genuity Group currently has a buy rating on the stock. A number of other analysts have also issued reports on CSTL. BTIG Research […]

Adeia (NASDAQ:ADEA – Free Report) had its price objective upped by Rosenblatt Securities from $17.00 to $20.00 in a research note issued to investors on Monday morning,Benzinga reports. Rosenblatt Securities currently has a buy rating on the stock. Several other equities research analysts also recently issued reports on ADEA. Weiss Ratings reaffirmed a “hold (c+)” […]

Guardant Health (NASDAQ:GH – Free Report) had its target price upped by Canaccord Genuity Group from $100.00 to $125.00 in a report released on Monday, Marketbeat reports. The firm currently has a buy rating on the stock. Several other equities analysts also recently commented on GH. Guggenheim boosted their price objective on Guardant Health from […]

Cytokinetics (NASDAQ:CYTK – Free Report) had its price objective upped by Citizens Jmp from $78.00 to $88.00 in a report issued on Monday morning,Benzinga reports. Citizens Jmp currently has a market outperform rating on the biopharmaceutical company’s stock. Several other analysts have also recently commented on the company. Weiss Ratings restated a “sell (d-)” rating […]

Natera (NASDAQ:NTRA – Get Free Report) had its price objective lifted by Canaccord Genuity Group from $250.00 to $285.00 in a research report issued to clients and investors on Monday,Benzinga reports. The brokerage presently has a “buy” rating on the medical research company’s stock. Canaccord Genuity Group’s price objective indicates a potential upside of 22.87% […]

Hut 8 (NASDAQ:HUT – Free Report) had its price target lifted by Keefe, Bruyette & Woods from $30.00 to $55.00 in a report published on Friday, MarketBeat Ratings reports. Keefe, Bruyette & Woods currently has an outperform rating on the stock. HUT has been the subject of several other research reports. Weiss Ratings restated a […]

Freshpet (NASDAQ:FRPT – Free Report) had its price target boosted by Bank of America from $60.00 to $67.00 in a research report released on Friday morning,Benzinga reports. The brokerage currently has a neutral rating on the stock. Several other analysts also recently issued reports on FRPT. Wells Fargo & Company lowered their price objective on […]

TTM Technologies (NASDAQ:TTMI – Free Report) had its price target hoisted by Truist Financial from $78.00 to $91.00 in a research note released on Friday,Benzinga reports. The brokerage currently has a buy rating on the technology company’s stock. A number of other research analysts have also weighed in on the company. Zacks Research upgraded TTM […]

Guardant Health (NASDAQ:GH – Free Report) had its price target increased by Mizuho from $100.00 to $120.00 in a research report released on Wednesday, MarketBeat.com reports. The brokerage currently has an outperform rating on the stock. A number of other analysts also recently issued reports on the company. Guggenheim raised their target price on Guardant […]

Lam Research (NASDAQ:LRCX – Free Report) had its target price boosted by Mizuho from $170.00 to $200.00 in a research note released on Wednesday morning, MarketBeat.com reports. The brokerage currently has an outperform rating on the semiconductor company’s stock. Several other equities analysts have also recently weighed in on LRCX. JPMorgan Chase & Co. raised […]

CSX (NASDAQ:CSX – Get Free Report) had its target price raised by equities researchers at Evercore ISI from $39.00 to $41.00 in a research report issued to clients and investors on Thursday,MarketScreener reports. The firm presently has an “outperform” rating on the transportation company’s stock. Evercore ISI’s price objective would indicate a potential upside of […]

Broadcom (NASDAQ:AVGO – Get Free Report) had its target price lifted by Truist Financial from $500.00 to $510.00 in a research note issued to investors on Friday,Benzinga reports. The firm presently has a “buy” rating on the semiconductor manufacturer’s stock. Truist Financial’s target price suggests a potential upside of 54.60% from the company’s previous close. […]

Analog Devices (NASDAQ:ADI – Get Free Report) had its price objective raised by stock analysts at Truist Financial from $258.00 to $291.00 in a research note issued on Friday, MarketBeat reports. The firm currently has a “hold” rating on the semiconductor company’s stock. Truist Financial’s price target would indicate a potential upside of 5.85% from […]

Disc Medicine (NASDAQ:IRON – Free Report) had its target price upped by Wells Fargo & Company from $91.00 to $109.00 in a research note issued to investors on Tuesday morning,Benzinga reports. They currently have an overweight rating on the stock. Several other analysts also recently issued reports on the company. Truist Financial upped their price […]

Immunome (NASDAQ:IMNM – Free Report) had its price objective increased by Evercore ISI from $18.00 to $40.00 in a report released on Tuesday morning, Marketbeat Ratings reports. They currently have an outperform rating on the stock. Other research analysts have also recently issued research reports about the company. Stephens raised their price target on Immunome […]

SiBone (NASDAQ:SIBN – Get Free Report) had its price target boosted by equities research analysts at Truist Financial from $21.00 to $23.00 in a research note issued on Thursday, Marketbeat Ratings reports. The firm presently has a “buy” rating on the stock. Truist Financial’s target price would indicate a potential upside of 16.66% from the […]

Pacific Biosciences of California (NASDAQ:PACB – Free Report) had its target price hoisted by Barclays from $1.50 to $2.00 in a report released on Monday,Benzinga reports. The firm currently has an equal weight rating on the biotechnology company’s stock. A number of other equities research analysts also recently issued reports on PACB. Piper Sandler boosted […]

Immunovant (NASDAQ:IMVT – Free Report) had its target price lifted by The Goldman Sachs Group from $18.00 to $28.00 in a report issued on Monday morning,Benzinga reports. The brokerage currently has a neutral rating on the stock. Other equities research analysts also recently issued research reports about the company. Weiss Ratings reaffirmed a “sell (d-)” […]

T. Rowe Price Group (NASDAQ:TROW – Get Free Report) had its price target upped by Morgan Stanley from $126.00 to $128.00 in a research note issued to investors on Wednesday,MarketScreener reports. The brokerage presently has an “equal weight” rating on the asset manager’s stock. Morgan Stanley’s target price would suggest a potential upside of 21.79% […]

Establishment Labs (NASDAQ:ESTA – Get Free Report) had its target price raised by research analysts at Mizuho from $85.00 to $90.00 in a research note issued to investors on Wednesday,Benzinga reports. The brokerage presently has an “outperform” rating on the stock. Mizuho’s price objective indicates a potential upside of 21.38% from the company’s current price. […]

Alphabet (NASDAQ:GOOGL – Get Free Report) had its price objective increased by investment analysts at BMO Capital Markets from $340.00 to $343.00 in a research note issued to investors on Tuesday,MarketScreener reports. The firm currently has an “outperform” rating on the information services provider’s stock. BMO Capital Markets’ price objective points to a potential upside […]

Gilead Sciences (NASDAQ:GILD – Free Report) had its price target lifted by HSBC from $110.00 to $133.00 in a research report report published on Wednesday morning,MarketScreener reports. The brokerage currently has a hold rating on the biopharmaceutical company’s stock. A number of other equities research analysts have also weighed in on the stock. Weiss Ratings […]

Aytu BioPharma (NASDAQ:AYTU – Free Report) had its target price hoisted by Ascendiant Capital Markets from $12.50 to $13.00 in a report issued on Wednesday morning,Benzinga reports. Ascendiant Capital Markets currently has a buy rating on the stock. Other equities research analysts have also recently issued research reports about the company. Maxim Group decreased their […]

Rivian Automotive (NASDAQ:RIVN – Get Free Report) had its price objective upped by equities research analysts at The Goldman Sachs Group from $13.00 to $16.00 in a research note issued on Friday,Benzinga reports. The brokerage currently has a “neutral” rating on the electric vehicle automaker’s stock. The Goldman Sachs Group’s price target points to a […]

lululemon athletica (NASDAQ:LULU – Get Free Report) had its price target lifted by investment analysts at Evercore ISI from $180.00 to $215.00 in a report issued on Friday,MarketScreener reports. Evercore ISI’s price objective suggests a potential upside of 14.97% from the stock’s previous close. Other analysts have also issued reports about the stock. BNP Paribas […]

Fluence Energy (NASDAQ:FLNC – Free Report) had its target price hoisted by Bank of America from $17.00 to $25.00 in a research note issued to investors on Tuesday morning,Benzinga reports. Bank of America currently has a neutral rating on the stock. Other equities analysts also recently issued research reports about the company. Canaccord Genuity Group […]

Maplebear (NASDAQ:CART – Get Free Report) had its target price increased by equities research analysts at Jefferies Financial Group from $41.00 to $48.00 in a report released on Thursday,Benzinga reports. The brokerage presently has a “hold” rating on the stock. Jefferies Financial Group’s target price would indicate a potential upside of 6.83% from the company’s […]